跳至主要内容
临床试验/NCT05769699
NCT05769699招募中不适用

Serum Biomarkers in Parkinson's Disease at Different Stages

Fondazione Policlinico Universitario Agostino Gemelli IRCCS2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年2月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
2
主要终点
Determine biooogical characteristics of parkinsonian patients in various stages of disease

研究概览

简要总结

  • Determine clinical characteristics of parkinsonian patients in various stages of disease;
  • Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease.
  • Measure vesicular neurodegeneration, synaptic and inflammation biomarkers

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria;
  • Age: 18-80 years;
  • Signature of informed consent to participate in this study
  • Exclusion criteria.
  • Women pregnant
  • Inflammatory or autoimmune diseases

排除标准

  • 未提供

结局指标

主要结局

Determine biooogical characteristics of parkinsonian patients in various stages of disease

时间窗: 3 years

dosage of serum IL-1b, IL6, IL-5, IL-4, IL17, TNFa, IFNg, IL10, total-alpha-synuclein, NfL, BDNF (ng/ml for all)

Determine clinical characteristics of parkinsonian patients in various stages of disease

时间窗: 3 years

Determine clinical characteristics of parkinsonian patients in various stages of disease by means of MDS-UPDRS score changes.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Serum Biomarkers in Parkinson's Disease at Different... | 临床试验